SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-190059
Filing Date
2018-06-12
Accepted
2018-06-12 08:30:34
Documents
4
Period of Report
2018-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d600642d8k.htm 8-K 20487
2 EX-10.1 d600642dex101.htm EX-10.1 11953
3 EX-99.1 d600642dex991.htm EX-99.1 16193
4 GRAPHIC g600642g33v97.jpg GRAPHIC 6287
  Complete submission text file 0001193125-18-190059.txt   58705
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 18893605
SIC: 2834 Pharmaceutical Preparations